FDA Grants Approval for Selexipag Application ANDA214055
The FDA has granted approval for the Selexipag application ANDA214055 submitted by RK Pharma.
Asset / Drug
Drug and asset intelligence for Selexipag with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.